儿童低级别胶质瘤疗效评估:RAPNO工作组共识建议
儿童低级别胶质瘤(pLGG)是儿童最常见的中枢神经系统肿瘤,其临床和生物学特征与成人不同,且发育中的儿童脑组织更易受肿瘤及治疗晚期毒性影响,因此成人RANO标准不适用。RAPNO工作组由国际儿童与成人神经肿瘤学家、放射科医生、放疗科医生和神经外科医生组成,通过文献回顾、现行实践和专家意见制定共识建议,涵盖影像学疗效评估及视路肿瘤视觉功能结局的补充指南,需在前瞻性临床试验中验证。
要点
- 儿童低级别胶质瘤疗效评估需考虑与成人不同的临床生物学特征及发育脑的晚期毒性。
- RAPNO共识建议包括影像学疗效评估及视路肿瘤视觉功能结局的补充指南。
- 该共识基于文献回顾、现行实践和专家意见,尚需前瞻性临床试验验证。
核心结论
- RAPNO工作组针对儿童低级别胶质瘤制定了包括影像学评估和视路肿瘤视觉功能结局在内的共识建议,需前瞻性试验验证。
研究设计与样本
- RAPNO工作组由国际儿童与成人神经肿瘤学家、临床医生、放射科医生、放疗科医生和神经外科医生组成,下设分委员会制定共识建议。
主要发现
- 儿童低级别胶质瘤的临床和生物学特征与成人不同,发育中的儿童脑组织更易受肿瘤及治疗晚期毒性影响。
- 儿童临床试验缺乏标准化疗效评估标准,导致研究间反应比较困难。
关键数值与推荐
- 共识建议包括影像学疗效评估,并针对视路肿瘤患者补充视觉功能结局指南。
临床怎么用
- 临床中可参考RAPNO共识建议对儿童低级别胶质瘤进行影像学疗效评估,并关注视路肿瘤患者的视觉功能结局。
局限性
- 建议基于文献回顾、现行实践和专家意见,尚需在前瞻性临床试验中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Paediatric low-grade gliomas (also known as pLGG) are the most common type of CNS tumours in children. In general, paediatric low-grade gliomas show clinical and biological features that are distinct from adult low-grade gliomas, and the developing paediatric brain is more susceptible to toxic late effects of the tumour and its treatment. Therefore, response assessment in children requires additional considerations compared with the adult Response Assessment in Neuro-Oncology criteria. There are no standardised response criteria in paediatric clinical trials, which makes it more difficult to compare responses across studies. The Response Assessment in Pediatric Neuro-Oncology working group, consisting of an international panel of paediatric and adult neuro-oncologists, clinicians, radiologists, radiation oncologists, and neurosurgeons, was established to address issues and unique challenges in assessing response in children with CNS tumours. We established a subcommittee to develop consensus recommendations for response assessment in paediatric low-grade gliomas. Final recommendations were based on literature review, current practice, and expert opinion of working group members. Consensus recommendations include imaging response assessments, with additional guidelines for visual functional outcomes in patients with optic pathway tumours. As with previous consensus recommendations, these recommendations will need to be validated in prospective clinical trials.
引用
- Fangusaro J, Witt O, Hernáiz Driever P, et al. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 2020. PMID: 32502457. doi:10.1016/S1470-2045(20)30064-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。